Sánchez-Aguilera Abel, Méndez-Ferrer Simón
Stem Cell Niche Pathophysiology Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Haematology, University of Cambridge, and National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, CB2 0PT, UK.
Cell Mol Life Sci. 2017 Feb;74(4):579-590. doi: 10.1007/s00018-016-2306-y. Epub 2016 Jul 19.
Research in the last decade has shown that hematopoietic stem cells (HSCs) interact with and are modulated by a complex multicellular microenvironment in the bone marrow, which includes both the HSC progeny and multiple non-hematopoietic cell types. Intense work is gradually throwing light on the composition of the HSC niche and the molecular cues exchanged between its components, which has implications for HSC production, maintenance and expansion. In addition, it has become apparent that bidirectional interactions between leukemic cells and their niche play a previously unrecognized role in the initiation and development of hematological malignancies. Consequently, targeting of the malignant niche holds considerable promise for more specific antileukemic therapies. Here we summarize the latest insights into HSC niche biology and recent work showing multiple connections between hematological malignancy and alterations in the bone marrow microenvironment.
过去十年的研究表明,造血干细胞(HSCs)与骨髓中复杂的多细胞微环境相互作用并受其调节,该微环境包括造血干细胞后代和多种非造血细胞类型。深入的研究正逐渐揭示造血干细胞龛的组成及其各组成部分之间交换的分子信号,这对造血干细胞的产生、维持和扩增具有重要意义。此外,白血病细胞与其龛之间的双向相互作用在血液系统恶性肿瘤的发生和发展中发挥了此前未被认识到的作用,这一点已变得很明显。因此,针对恶性龛的靶向治疗在更特异性的抗白血病治疗方面具有巨大潜力。在此,我们总结了对造血干细胞龛生物学的最新见解以及近期显示血液系统恶性肿瘤与骨髓微环境改变之间存在多种联系的研究工作。